These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7475677)

  • 1. Risperidone-induced extrapyramidal reactions.
    Mahmood T; Clothier EB; Bridgman R
    Lancet; 1995 Nov; 346(8984):1226. PubMed ID: 7475677
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risperidone].
    Zolk O; Thürauf N
    Dtsch Med Wochenschr; 2003 Jun; 128(24):1353-6. PubMed ID: 12802745
    [No Abstract]   [Full Text] [Related]  

  • 3. Rabbit syndrome secondary to risperidone.
    Hoy JS; Alexander B
    Pharmacotherapy; 2002 Apr; 22(4):513-5. PubMed ID: 11939686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction and assessment of extrapyramidal side effects induced by risperidone based on dopamine D(2) receptor occupancy.
    Yamada Y; Ohno Y; Nakashima Y; Fukuda M; Takayanagi R; Sato H; Tsuchiya F; Sawada Y; Iga T
    Synapse; 2002 Oct; 46(1):32-7. PubMed ID: 12211096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal-emergent rabbit syndrome during dose reduction of risperidone.
    Nishimura K; Tsuka M; Horikawa N
    Eur Neuropsychopharmacol; 2001 Aug; 11(4):323-4. PubMed ID: 11532387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug interaction between risperidone and phenytoin resulting in extrapyramidal symptoms.
    Sanderson DR
    J Clin Psychiatry; 1996 Apr; 57(4):177. PubMed ID: 8601557
    [No Abstract]   [Full Text] [Related]  

  • 7. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
    Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
    Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sudden dysphagia with uvular enlargement following the initiation of risperidone which responded to benztropine: was this an extrapyramidal side effect?
    Nair S; Saeed O; Shahab H; Sedky K; Garver D; Lippmann S
    Gen Hosp Psychiatry; 2001; 23(4):231-2. PubMed ID: 11569473
    [No Abstract]   [Full Text] [Related]  

  • 9. Searching for functional SNPs or rare variants in exonic regions of DRD3 in risperidone-treated patients.
    Gassó P; Mas S; Oliveira C; Bioque M; Parellada E; Bernardo M; Trias G; Comeche J; Lafuente A
    Eur Neuropsychopharmacol; 2011 Apr; 21(4):294-9. PubMed ID: 20619616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone.
    Lang DJ; Kopala LC; Vandorpe RA; Rui Q; Smith GN; Goghari VM; Honer WG
    Am J Psychiatry; 2001 Apr; 158(4):625-31. PubMed ID: 11282699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia.
    Lang DJ; Kopala LC; Vandorpe RA; Rui Q; Smith GN; Goghari VM; Lapointe JS; Honer WG
    Am J Psychiatry; 2004 Oct; 161(10):1829-36. PubMed ID: 15465980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapyramidal Symptoms During Risperidone Maintenance Treatment in Schizophrenia: A Prospective, Multicenter Study.
    Bo QJ; Li XB; Wang ZM; Li AN; Ma X; Wang CY
    J Clin Psychopharmacol; 2016 Apr; 36(2):125-9. PubMed ID: 26848792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of novel antipsychotic drugs.
    Raleigh F
    Pharmacotherapy; 1996; 16(6 Pt 2):160S-165S; discussion 166S-168S. PubMed ID: 8948000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone augmentation with amisulpride: the blue-tongue sign.
    Yun HW; Lee BD
    Psychiatry Clin Neurosci; 2012 Aug; 66(5):464-5. PubMed ID: 22834673
    [No Abstract]   [Full Text] [Related]  

  • 15. Extrapyramidal syndrome and long-acting injectable risperidone.
    Adamou M; Hale AS
    Am J Psychiatry; 2004 Apr; 161(4):756-7. PubMed ID: 15056527
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome with risperidone.
    Gleason PP; Conigliaro RL
    Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone.
    Windhaber J; Urbanits S; Grisold W
    Neurology; 2000 Apr; 54(7):1543-4. PubMed ID: 10751282
    [No Abstract]   [Full Text] [Related]  

  • 18. [Longitudinal comparative study of risperidone vs classical neuroleptics in the treatment of schizophrenia: 24 months of observation].
    Bouchard RH
    Encephale; 2002; 28 Spec No 2 Pt 2():S31-2. PubMed ID: 12587355
    [No Abstract]   [Full Text] [Related]  

  • 19. On the extrapyramidal side-effects of antipsychotics with combined dopamine and 5-HT-blocking effects.
    Sher L
    Med Hypotheses; 1998 Mar; 50(3):267-8. PubMed ID: 9578333
    [No Abstract]   [Full Text] [Related]  

  • 20. Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone.
    de Haan L; Lavalaye J; Linszen D; Dingemans PM; Booij J
    Am J Psychiatry; 2000 Jun; 157(6):1019-20. PubMed ID: 10831489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.